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Background: In this day and age, the 
increased use of traditional communication 
tools in the work environment such as 
physical white boards, sticky notes, and 







are the main concerns. The need for reliable, 
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laboratory digital whiteboards is becoming 
obvious, especially with the exponentially 
increasing amount of molecular genetic 
testing performed as part of daily clinical 
practice. The use of commercial systems 
is limited by high initial investment 
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implementation, and the lack of ability to be 
customized.
Methods: We designed an internal laboratory 
digital whiteboards system using Microsoft 





the platform through desktop computers 
and secure mobile device applications. Two 
main plans were created in MS planner: 1) 
Molecular Diagnostic Team plan; and 2) 
Heme Team plan. Each plan was divided 
into buckets (e.g. pending cases, to do 
list, clinical runs by date, current lab 
issues, quality control, improvements, and 
individual molecular pathologist’s assigned 
cases progress). During the transition phase, 
the implementation of the new system 
was assessed and edited daily during the 
laboratory daily huddle. Afterwards, to 
evaluate the impact of digital whiteboards 
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assessment was performed using an online 
survey questionnaire.
Results: An online survey was developed 
and sent to the participants who used the 
platform over a period of four months. In total, 
58.3% responded by the time of collecting 
the survey responses. All of the respondents 
did use Microsoft planner for laboratory 
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thought it was useful to switch to a digital 
version of whiteboard, 100% prefered using 
the platform over the conventional methods, 
100% thought that the new platform improved 
communication between lab personnel, 100% 
thought that switching to the new platform 
+'*##
that switching to the new platform improved 
communication with pathologists and 
trainees, 71% thought that switching to the 
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thought that switching reduced the time spent 
tracking cases.
Conclusion: Switching daily molecular 
laboratory case annotation and tracking 
system to a digital format may improve 
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Background: Cancer-related abdominal 
pain is a common symptom associated with 
upper intra-abdominal carcinoma, especially 




medical practitioners. Typically, cancer pain 
can be managed by following the World 
Health Organization 3-step analgesic ladder. 
However, analgesic use of opioids, the 
mainstay treatment for moderate-to-severe 
cancer-related pain, may be ineffective in a 
subset of cancer patients. Escalation of dosage 
may be limited by opioid-induced side effects. 
Thus, with 70-80% of advance-staged patients, 
and up to 90% of those with bone metastases, 
suffering from pain, ablative procedures 
including neurolysis of the celiac/splanchnic 
plexus should be sought to improve analgesic 
outcomes (1). Our objective was to review the 
literature addressing the effect of neurolytic 
celiac plexus block (NCPB) on the palliation 
of pain emanating from advanced upper intra-
abdominal malignancies.
Methods: Electronic databases including 
Medline/PubMed, EMBASE, and Cochrane 
Library were searched. Only studies with a 
high level of evidence were reviewed. These 
included prospective randomized control 
studies, systematic reviews and meta-analyses. 
Further, references from included articles 
were carefully reviewed for additional 
relevant trials.






analyses, and one Cochrane review article 
were found to meet eligibility criteria.
Conclusion: Neurolysis of the celiac/
splanchnic plexus is an effective and 
safe therapeutic modality that should be 
considered early for palliation of cancer-
related pain in advanced upper intra-
abdominal malignancies. This is especially 
true for patients with intolerable opioid-
induced adverse events and painful symptoms 
resistant to oral analgesics. 
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